Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia?

Journal of Cardiothoracic Surgery

Volumn 6, Issue 1, 2011, Pages

  Sahin, Mehmet A ^a   Yucel, Orhan ^a   Guler, Adem ^a   Doganci, Suat ^a   Jahollari, Artan ^a   Cingoz, Faruk ^a   Arslan, Siddik ^b   Gamsizkan, Mehmet ^a   Yaman, Halil ^a   Demirkilic, Ufuk ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; TAURINE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; ENZYMOLOGY; HEART INFARCTION PREVENTION; HEART MUSCLE; LIPID PEROXIDATION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; SPECTROPHOTOMETRY; TREATMENT OUTCOME;

ANIMALS; CATALASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; TAURINE; TREATMENT OUTCOME;

EID: 79952702859     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-31     Document Type: Article

References (32)

1. Jahania MS, Sanchez JA, Narayan P, Lasley RD, Mentzer RM. Heart Preservation for Transplantation: Principles and Strategies. Ann Thorac Surg 1999, 68(5):1983-7. 10.1016/S0003-4975(99)01028-0, 10585116.
2. Ueno T, Iguro Y, Yotsumoto G, Fukumoto Y, Nakamura K, Miyamoto TA, Sakata R. Taurine at early reperfusion significantly reduces myocardial damage and preserves cardiac function in the isolated rat heart. Resuscitation 2007, 73(2):287-95. 10.1016/j.resuscitation.2006.12.011, 17353077.
3. Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 2005, 20(6):278-85. 10.1007/s00380-005-0841-9, 16314910.
4. Miyamoto TA, Ueno T, Iguro Y, Yotsumoto G, Fukumoto Y, Nakamura K, Sakata R. Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior to ischemia. Adv Exp Med Biol 2009, 643:27-36. full_text, 19239133.
5. Huxtable RJ. Physiological actions of Taurine. Physiol Rev 1992, 72(1):101-63.
6. Oz E, Erbaş D, Gelir E, Aricioǧlu A. Taurine and calcium interaction in protection of myocardium exposed to ischemic reperfusion injury. Gen Pharmacol 1999, 33(2):137-141. 10.1016/S0306-3623(98)00284-5, 10461851.
7. Pion PD, Kittleson MD, Thomas WP, Delellis LA, Rogers QR. Response of cats with dilated cardiomyopathy to Taurine supplementation. J Am Vet Med Assoc 1992, 201(2):275-84.
8. Welty MC, Welty JD, McBroom MJ. Effect of isoproterenol and Taurine on heart calcium in normal and cardiomyopathic hamsters. J Mol Cell Cardiol 1982, 14(6):353-7. 10.1016/0022-2828(82)90250-4, 7131567.
9. Yucel O, Kunak ZI, Macit E, Gunal A, Gozubuyuk A, Gul H, Genc O. Protective efficacy of Taurine against pulmonary edema progression: experimental study. J Cardiothorac Surg 2008, 3:57. 10.1186/1749-8090-3-57, 2583976, 18957088.
10. Hoffmeyer MR, Scalia R, Ross CR, Jones SP, Lefer DJ. PR-39, a potent neutrophil inhibitor attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2000, 279(6):H2824-8.
11. Zhu J, Qiu Y, Wang Q, Zhu Y, Hu S, Zheng L, Wang L, Zhang Y. Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats. European Journal of Cardio-thoracic Surgery 2008, 34:661-666. 10.1016/j.ejcts.2008.05.035, 18583145.
12. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-31. full_text, 2233309.
13. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34(3):497-500.
14. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70(1):158-69.
15. Aebi H. Methods of enzymatic analysis. 1974, 2:673-684. Academic Press, New York and London, Bergmeyer HU, 2.
16. McCrystal GD, Pepe S, Esmore DS, Rosenfeldt FL. The Challenge of Improving Donor Heart Preservation. Heart Lung Circ 2004, 13(1):74-83. 10.1016/j.hlc.2004.01.027, 16352173.
17. Redmond HP, Stapleton PP, Neary P, Bouchier-Hayes D. Immunonutrition: the role of Taurine. Nutrition 1998, 14(7-8):599-604. 10.1016/S0899-9007(98)00097-5, 9684263.
18. Schaffer S, Azuma J, Takahashi K, Mozaffari M. Why is Taurine cytoprotective?. Adv Exp Med Biol 2003, 526:307-321.
19. Wójcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y. The potential protective effects of Taurine on coronary heart disease. Atherosclerosis 2010, 208(1):19-25. 2813349, 19592001.
20. Mizushima S, Nara Y, Sawamura M, Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 1996, 403:615-22.
21. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y, . WHO-Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 2001, 24(4):453-7. 10.1291/hypres.24.453, 11510759, WHO-Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group.
22. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. Reduction of reperfusion injury with preoperative rapid intravenous infusion of Taurine during myocardial revascularization. Am Heart J 1992, 123(2):339-345. 10.1016/0002-8703(92)90644-B, 1736568.
23. Briet F, Keith M, Leong-Poi H, Kadakia A, Aba-Alkhail K, Giliberto JP, Stewart D, Errett L, David C. Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats. Nutr Metab Cardiovasc Dis 2008, 18(10):691-9. 10.1016/j.numecd.2007.10.003, 18359616.
24. Orrenius S, Burkitt MJ, Kass GE, Dypbukt JM, Nicotera P. Calcium ions and oxidative cell injury. Ann Neurol 1992, 32(Suppl):S33-42. 10.1002/ana.410320708, 1510379.
25. Homer-Vanniasinkam S, Crinnion JN, Gough MJ. Post-ischaemic organ dysfunction: A review. Eur J Vasc Endovasc Surg 1997, 14(3):195-203. 10.1016/S1078-5884(97)80191-8, 9345239.
26. Jennings RB, Reimer KA. Acute myocardial ischemia: effects of reperfusion with arterial blood. Artif Cells Blood Substit Immobil Biotechnol 1994, 22(2):253-78. 10.3109/10731199409117419, 8087247.
27. Molina H, García M. Enzymatic defenses of the rat heart against lipid peroxidation. Mech Ageing Dev 1997, 97(1):1-7. 10.1016/S0047-6374(97)01876-9, 9223121.
28. Kim HS, Kwack SJ, Lee BM. Lipid peroxidation, antioxidant enzymes, and benzoapyrene-quinones in the blood of rats treated with benzoapyrene. Chemico-Biological Interactions 2000, 127(2):139-150. 10.1016/S0009-2797(00)00177-0, 10936229.
29. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312(3):159-63. 10.1056/NEJM198501173120305, 2981404.
30. Bolcal C, Yildirim V, Doganci S, Sargin M, Aydin A, Kuralay E, Ozal E, Demirkilic U, Oz BS, Sayal A, Tatar H. Do N-acetylcystein, beta-glucan, and coenzyme Q10 mollify myocardial ischemia-reperfusion injury?. Heart Surg Forum 2007, 10(3):E222-7. 10.1532/HSF98.20061195, 17599896.
31. Ergun Y, Oksuz H, Atli Y, Kilinç M, Darendeli S. Ischemia-Reperfusion Injury in Skeletal Muscle: Comparison of the Effects of Subanesthetic Doses of Ketamine, Propofol, and Etomidate. J Surg R 2010, 159(1):e1-e10.
32. Ogawa T, Mimura Y. Antioxidant effect of zinc on acute renal failure induced by ischemia-reperfusion injury in rats. Am J Nephrol 1999, 19(5):609-14. 10.1159/000013529, 10575193.